Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by The PERT Consortium®

evt | Article | July 2020 Supplement

Introduction

By Brent Keeling, MD, and Richard Channick, MD

Sponsored by The PERT Consortium®

evt | Article | July 2021 Supplement

Advancing PE Care, Promoting Research

By Brent Keeling, MD, and Soophia Naydenov, MD

Sponsored by AngioDynamics, Inc.

evt | Article | February 2021

The Right Device in Right Heart: AngioVac System for Clot in Transit and Right Heart Vegetation

By William Brent Keeling, MD; Abdul Haseeb Qazi, MD; and Kenneth Rosenfield, MD

evt | Article | July 2024

Ask The Experts: What Does PE Intervention Look Like in 2034?

Experts consider the role of PERTs, technologic advances, and the state of research and data in the next 10 years.

With Brent Keeling, MD; Robert A. Lookstein, MD, MHCDL, FSIR, FAHA, FSVM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM; and Frances Mae West, MD, MS, FACP

Advertisement

evt | Article | January 2023

PE Response Teams: Evolution Within the Revolution

Early adopters of the PERT concept share practical insights on forming an effective team.

Moderator: Rachel P. Rosovsky, MD, MPH;
Panelists: George Davis, PharmD; James Horowitz, MD; Brent Keeling, MD; Vicki McNally, MSN, RN, NP; John Moriarty, MD, FSIR; Soophia Naydenov, MD, FCCP; Fionnuala Ní Áinle, MD, PhD; and Charles B. Ross, MD, FACS, DFSVS

Sponsored by The PERT Consortium™

evt | Article | July 2023 Supplement

PE Looks Like Me: A New Initiative From The National PERT Consortium™

Bridging the gap between providers and patients to raise awareness of PE and open the discussion on prevention of PE on a broader level.

By Brent Keeling, MD; Amy Ranier, MPM; and Scott Kaatz, DO, MSc, FACP, SFHM

Sponsored by The PERT Consortium™

evt | Article | July 2024 Supplement

Enhancing Pulmonary Embolism
Treatment: Insights From the APEX-AV Study on the AlphaVac F1885 Catheter

A summary of the study’s findings and their implications on managing patients with acute intermediate-risk PE.

By Brent Keeling, MD; Mona Ranade, MD; and Seth Sokol, MD

evt | Article | January 2021

Panel Discussion: Core Elements and Key Adjustments Made for Modern PE Teams

A panel discussion on the essential components of a pulmonary embolism response team, who should be involved, and how to handle communication among team members.

With Jay Giri, MD, MPH; Brent Keeling, MD; and Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM

evt | Article | July 2025

PE in Prime Time: New Pathways, Devices, and Trials

A comprehensive conversation about the state of pulmonary embolism care today, including keys to a strong program, use of artificial intelligence, typical interventional pathways, approaches to trial enrollment, and more.

With Gregory Piazza, MD, MS; Akhilesh Sista, MD, FSIR, FAHA; Brent Keeling, MD; Saher Sabri, MD; and Mona Ranade, MD

evt | News | January 13, 2025

AngioDynamics’ AlphaVac F1885 System’s APEX-AV Trial Results Published

January 13, 2025—AngioDynamics, Inc. announced that the results from the APEX-AV trial, which evaluated acute pulmonary embolism (PE) extraction with the company’s AlphaVac F18⁸⁵ system, were published by Mona Ranade, MD, et al online in JSCAI, the Journal of the Society for Cardiovascular Angiography & Interventions.

evt | Article | July 2025

Current Concepts in Venous Care

By Kathleen Gibson, MD

evt | News | April 27, 2022

AngioDynamics Launches APEX-AV Study in Partnership with PERT Consortium

April 27, 2022—AngioDynamics, Inc. announced the launch of APEX-AV, the “Acute Pulmonary Embolism Extraction Trial with the AlphaVac System” clinical study, which is aimed at evaluating the efficacy and safety of the company’s AlphaVac multipurpose mechanical aspiration (MMA) F1885 system in the treatment of acute intermediate-risk pulmonary embolism (PE).

evt | News | May 3, 2024

APEX-AV Trial Evaluates AngioDynamics’ AlphaVac F1885 Mechanical Thrombectomy System to Treat PE

May 3, 2024—The safety and efficacy results from the APEX-AV trial of acute pulmonary embolism (PE) extraction with the AlphaVac F1885 aspiration system (AngioDynamics, Inc.) demonstrated that catheter-directed mechanical thrombectomy is safe and effective in patients with acute intermediate-risk PE with significant improvement in the right ventricle (RV) function and minimal major adverse events.

Sponsored by The PERT Consortium™

evt | Article | July 2023 Supplement

Pulmonary Embolism Clinical Trial Updates

Trial principal investigators provide insight into and updates to the APEX-AV, PE-TRACT, HI-PEITHO, and STORM-PE studies.

With Mona Ranade, MD; Akhilesh Sista, MD, FSIR, FAHA; Stavros V. Konstantinides, MD; Kenneth Rosenfield, MD, MHCDS; and Rachel P. Rosovsky, MD, MPH

evt | News | April 4, 2024

AngioDynamics’ AlphaVac F18⁸⁵ System Receives FDA Clearance for Treatment of PE

April 4, 2024—AngioDynamics, Inc. announced FDA 510(k) clearance for the AlphaVac F1885 system for the treatment of pulmonary embolism (PE).

evt | News | December 7, 2023

AngioDynamics Completes Enrollment in APEX-AV Acute PE Trial

December 7, 2023—AngioDynamics, Inc. announced the completion of patient enrollment in the APEX-AV trial of acute pulmonary embolism (PE) extraction with the company’s AlphaVac multipurpose mechanical aspiration (MMA) F1885 system.

evt | Article | January 2021

Vascular Emergencies: Challenges and Solutions

By Melissa Kirkwood, MD

evt | News | October 31, 2022

AngioDynamics Commences APEX-AV Study to Assess AlphaVac F18⁸⁵ System in Treatment of PE

October 31, 2022—AngioDynamics, Inc. announced the enrollment of the first patient in the “Acute Pulmonary Embolism Extraction Trial With the AlphaVac System” (APEX-AV) clinical study at Jacobi Medical Center in New York, New York.

Sponsored by The PERT Consortium™

evt | Article | July 2022 Supplement

Rationale for the APEX-AV, HI-PEITHO, and PE-TRACT Trials

A review of the objectives, study design, outcome measures, and potential impact of three upcoming pulmonary embolism studies.

By Mona Ranade, MD; Peter Monteleone, MD; and Akhilesh K. Sista, MD

Sponsored by The PERT Consortium™

evt | Article | July 2023 Supplement

On the Horizon of PE Care

An update from The National PERT Consortium™.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button